The economic downturn has hurt European companies in the microtechnology, nanotechnology and advanced materials industries, according to a survey by IVAM Research completed in December 2009. The sector accounted for nearly €44 billion ($62 billion) in revenues in 2009 and had 310,000 employees. Twenty-seven percent of the companies surveyed reported a decline of more than […]
Downsizing, outsourcing and restructuring continue to be major themes for R&D operations at the world’s largest pharmaceutical companies. Since fall of 2009, five major drug companies have announced R&D restructurings. In fact, for most of these companies, the latest announcements are extensions of similar efforts within the last two years to improve R&D productivity and […]
According to a Chemical & Engineering News (C&EN) survey, 15 US chemical companies plan to increase capital spending 9.4% on average this year to $8,263 million. In 2009, the companies cut capital spending by an average of 27.5%. Ten firms plan to increase capital spending. C&EN forecasts the firms’ capital expenditures to be 5.1% of […]
PetroChina heads PFC Energy’s latest ranking of the top 50 listed energy groups according to market capitalization. PetroChina and other national oil groups had slipped in the rankings last year due to the economic crisis. PetroChina, which first ascended to number one in 2007, has a market value of $353.1 billion. Market values for national […]
There are 267 bioscience organizations in New Zealand, 117 of which work in the area of innovative foods and human nutrition, and 114 of which work in the area of human biomedical science and drug discovery. Of the 267 bioscience organizations, 46% are “active” organizations, meaning that they operate in other fields, but use bioscience […]
Last year, the FDA’s Center for Drug Evaluation and Research (CDER) approved 19 new molecular entities, compared to 21 the year before. The CDER also approved six biologic license applications, up from three in 2008. New biologics accounted for 24% of new approvals, the highest percentage ever. The highest number of approvals were for cancer […]
Company Announcements Sigma-Aldrich now exclusively distributes Stemgent’s portfolio of lentivirus-based delivery systems for the generation of induced Pluripotent Stem (iPS) cells. Cisbio Biosassays established sales operations in China and South Korea in November 2009. Representatives of febit, GENEART, Ginkgo BioWorks, Biosearch Technologies and Sutro Biopharma are among the founding members of the Synthetic Biology Industry […]
Company Announcements Protein Discovery and New Objective announced a strategic comarketing and development agreement for Protein Discovery’s GELFREE 8100 Fractionation System and New Objective’s PicoFrit nanobore chromatography columns and Digital PicoView nanospray sources. Denator AB announced the completion of a fourth round of financing in fall 2009 that raised SEK 15 million ($2.2 million). In […]
The Higher Education Funding Council (HEFCE) this month announced funding for the 2010–11 academic year (August 1–July 31) of £7,356 million ($11,753 million), compared to £7,809 million last year. The HEFCE distributes government money to England’s universities and colleges. Funding for recurrent grants for teaching, research and the Higher Innovation Fund (HEIF) increased 0.9%, and […]
Company Announcements Malvern Instruments and Kaiser Optical Systems entered into a development collaboration agreement to integrate their respective Morphologi platform and RamanRxn System analyzers. Kaiser will also distribute an exclusive version of Malvern’s ISys software and a new system control platform software for its Raman Microprobe and Raman WorkStation range. Malvern Instruments announced it will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
